143 related articles for article (PubMed ID: 8980909)
1. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
Kobayashi H; Gotoh J; Terao T
Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
[TBL] [Abstract][Full Text] [Related]
2. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
Kobayashi H; Sugino D; Terao T
Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
[TBL] [Abstract][Full Text] [Related]
3. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator.
Niedbala MJ; Stein-Picarella M
Blood; 1993 May; 81(10):2608-17. PubMed ID: 7683925
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
5. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways.
Kobayashi H; Suzuki M; Tanaka Y; Hirashima Y; Terao T
J Biol Chem; 2001 Jan; 276(3):2015-22. PubMed ID: 11050091
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
[TBL] [Abstract][Full Text] [Related]
8. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor.
Kobayashi H; Suzuki M; Sun GW; Hirashima Y; Terao T
Biochim Biophys Acta; 2000 Sep; 1481(2):310-6. PubMed ID: 11018722
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C synergistically stimulates tumor necrosis factor-alpha-induced secretion of urokinase-type plasminogen activator in human dental pulp cells.
Hashizume H; Kamio N; Nakao S; Matsushima K; Sugiya H
J Physiol Sci; 2008 Feb; 58(1):83-6. PubMed ID: 18177545
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon.
Niedbala MJ; Picarella MS
Blood; 1992 Feb; 79(3):678-87. PubMed ID: 1732009
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
Niedbala MJ; Stein M
Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
[TBL] [Abstract][Full Text] [Related]
12. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha inhibition of 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) expression.
Li X; Youngblood GL; Payne AH; Hales DB
Endocrinology; 1995 Aug; 136(8):3519-26. PubMed ID: 7628389
[TBL] [Abstract][Full Text] [Related]
14. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
Gyetko MR; Shollenberger SB; Sitrin RG
J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
[TBL] [Abstract][Full Text] [Related]
15. Induction of intercellular adhesion molecule-1 by tumor necrosis factor-alpha through the 55-kDa receptor is dependent on protein kinase C in human retinal pigment epithelial cells.
Sippy BD; Hofman FM; Wright AD; Wang JL; Gopalakrishna R; Gundimeda U; He S; Ryan SJ; Hinton DR
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):597-606. PubMed ID: 8595959
[TBL] [Abstract][Full Text] [Related]
16. Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells.
Aguirre Ghiso JA; Alonso DF; Farías EF; Bal de Kier Joffé E
Biochim Biophys Acta; 1997 Apr; 1356(2):171-84. PubMed ID: 9150275
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
Ziegler A; Knesel J; Fabbro D; Nagamine Y
J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
[TBL] [Abstract][Full Text] [Related]
19. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
20. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
Kobayashi H; Suzuki M; Kanayama N; Terao T
Clin Exp Metastasis; 2004; 21(2):159-66. PubMed ID: 15168733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]